|
OMIM |
Link |
Information gain |
01 |
|
oslam syndrome
|
[NCBI]
|
0.0012039
|
|
|
reticular dysgenesia
|
[NCBI]
|
0.00110387
|
|
|
immunoglobulin m, level of
|
[NCBI]
|
0.00095223
|
|
|
IGAD1
|
[NCBI]
|
0.000754543
|
|
|
TNF
|
[NCBI]
|
0.00021096
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
0.000171297
|
|
|
combined inflammatory and immunologic defect
|
[NCBI]
|
0.000150426
|
|
|
RA
|
[NCBI]
|
0.000102208
|
|
|
PGLYRP1
|
[NCBI]
|
8.66321e-05
|
|
|
AEZ
|
[NCBI]
|
7.99246e-05
|
|
|
hypoascorbemia
|
[NCBI]
|
7.83928e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
6.5778e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
6.35819e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
6.35819e-05
|
|
|
ENTPD1
|
[NCBI]
|
5.98921e-05
|
|
|
HIGM1
|
[NCBI]
|
5.9819e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
5.92574e-05
|
|
|
SEMA7A
|
[NCBI]
|
5.82977e-05
|
|
|
ED1
|
[NCBI]
|
5.16025e-05
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
5.08751e-05
|
|
|
CHH
|
[NCBI]
|
4.85302e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
4.82719e-05
|
|
|
menkes disease
|
[NCBI]
|
4.70185e-05
|
|
|
PSORS1
|
[NCBI]
|
4.45732e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
4.30306e-05
|
|
|
TLR5
|
[NCBI]
|
3.68693e-05
|
|
|
PGLYRP4
|
[NCBI]
|
3.50547e-05
|
|
|
PGLYRP3
|
[NCBI]
|
3.50547e-05
|
|
|
TLR4
|
[NCBI]
|
3.48448e-05
|
|
|
ADA
|
[NCBI]
|
3.36859e-05
|
|
|
SPRR2A
|
[NCBI]
|
3.19458e-05
|
|
|
DUSP10
|
[NCBI]
|
3.19458e-05
|
|
|
PGLYRP2
|
[NCBI]
|
2.99283e-05
|
|
|
ITGA1
|
[NCBI]
|
2.99283e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.864e-05
|
|
|
SESN1
|
[NCBI]
|
2.72353e-05
|
|
|
ST3GAL4
|
[NCBI]
|
2.72353e-05
|
|
|
PRL
|
[NCBI]
|
2.57058e-05
|
|
|
MICB
|
[NCBI]
|
2.53945e-05
|
|
|
complement component c1r deficiency
|
[NCBI]
|
2.4653e-05
|
|
|
HAVCR1
|
[NCBI]
|
2.39947e-05
|
|
|
PDCD1LG1
|
[NCBI]
|
2.34028e-05
|
|
|
CD80
|
[NCBI]
|
2.34028e-05
|
|
|
IRF5
|
[NCBI]
|
2.28653e-05
|
|
|
CVID
|
[NCBI]
|
2.22429e-05
|
|
|
TBXA2R
|
[NCBI]
|
2.14978e-05
|
|
|
IL2
|
[NCBI]
|
2.14075e-05
|
|
|
WAS
|
[NCBI]
|
2.12545e-05
|
|
|
SEMA4D
|
[NCBI]
|
2.1105e-05
|
|
|
PGF
|
[NCBI]
|
2.0737e-05
|
|
|
ITGB1
|
[NCBI]
|
1.91824e-05
|
|
|
MAP3K7
|
[NCBI]
|
1.8916e-05
|
|
|
CRIP1
|
[NCBI]
|
1.86613e-05
|
|
|
TRAF6
|
[NCBI]
|
1.84175e-05
|
|
|
GZMA
|
[NCBI]
|
1.77424e-05
|
|
|
MYD88
|
[NCBI]
|
1.77424e-05
|
|
|
IFNGR1
|
[NCBI]
|
1.7534e-05
|
|
|
KLRK1
|
[NCBI]
|
1.71387e-05
|
|
|
PTX3
|
[NCBI]
|
1.71387e-05
|
|
|
CD40LG
|
[NCBI]
|
1.69508e-05
|
|
|
CRH
|
[NCBI]
|
1.63534e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.6176e-05
|
|
|
MICA
|
[NCBI]
|
1.56371e-05
|
|
|
C4B
|
[NCBI]
|
1.54924e-05
|
|
|
LIF
|
[NCBI]
|
1.53514e-05
|
|
|
HIF1A
|
[NCBI]
|
1.52138e-05
|
|
|
MBL2
|
[NCBI]
|
1.51929e-05
|
|
|
CTLA4
|
[NCBI]
|
1.50796e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.50399e-05
|
|
|
C4A
|
[NCBI]
|
1.46951e-05
|
|
|
MAPK14
|
[NCBI]
|
1.45726e-05
|
|
|
A2M
|
[NCBI]
|
1.34769e-05
|
|
|
JAK3
|
[NCBI]
|
1.26486e-05
|
|
|
SOCS3
|
[NCBI]
|
1.25639e-05
|
|
|
CCL2
|
[NCBI]
|
1.23175e-05
|
|
|
MAPK3
|
[NCBI]
|
1.22378e-05
|
|
|
PARP1
|
[NCBI]
|
1.17108e-05
|
|
|
HP
|
[NCBI]
|
1.16834e-05
|
|
|
BTK
|
[NCBI]
|
1.08524e-05
|
|
|
VIP
|
[NCBI]
|
1.03845e-05
|
|
|
CD
|
[NCBI]
|
9.94834e-06
|
|
|
MAPK1
|
[NCBI]
|
9.66073e-06
|
|
|
TLR9
|
[NCBI]
|
9.33338e-06
|
|
|
UCP2
|
[NCBI]
|
9.19938e-06
|
|
|
STAT1
|
[NCBI]
|
8.16933e-06
|
|
|
VASP
|
[NCBI]
|
7.95983e-06
|
|
|
LEP
|
[NCBI]
|
7.79205e-06
|
|
|
ACADM
|
[NCBI]
|
7.63004e-06
|
|
|
MPO
|
[NCBI]
|
7.29168e-06
|
|
|
VEGF
|
[NCBI]
|
6.86781e-06
|
|
|
BCR
|
[NCBI]
|
5.57214e-06
|
|
|
APRT
|
[NCBI]
|
5.49317e-06
|
|
|
SERPINA6
|
[NCBI]
|
5.30222e-06
|
|
|
HDC
|
[NCBI]
|
5.10222e-06
|
|
|
CF
|
[NCBI]
|
5.02645e-06
|
|
|
STAT3
|
[NCBI]
|
3.73698e-06
|
|
|
GHRH
|
[NCBI]
|
3.39082e-06
|
|
|
ACHE
|
[NCBI]
|
3.3439e-06
|
|
|
NGFB
|
[NCBI]
|
3.2075e-06
|
|
|
AVP
|
[NCBI]
|
3.09856e-06
|
|
|
PF4
|
[NCBI]
|
2.67423e-06
|
|
|
ACE
|
[NCBI]
|
2.63174e-06
|
|
|
SLE
|
[NCBI]
|
2.47873e-06
|
|
|
CYP1A1
|
[NCBI]
|
2.26286e-06
|
|
|
EPO
|
[NCBI]
|
2.25848e-06
|
|
|
ALB
|
[NCBI]
|
2.10057e-06
|
|
|
PYY
|
[NCBI]
|
2.0136e-06
|
|
|
BDNF
|
[NCBI]
|
1.76198e-06
|
|
|
ADCYAP1
|
[NCBI]
|
1.39905e-06
|
|
|
NPY
|
[NCBI]
|
1.05362e-06
|
|
|
TF
|
[NCBI]
|
9.00542e-07
|
|
|
APOB
|
[NCBI]
|
5.63562e-07
|
|
|
SPP1
|
[NCBI]
|
5.58635e-07
|
|
|
MBP
|
[NCBI]
|
4.01164e-07
|
|
|
LPL
|
[NCBI]
|
3.53205e-07
|
|
|
AFP
|
[NCBI]
|
3.32747e-07
|
|
|
APOE
|
[NCBI]
|
2.213e-07
|
|
|
NPPA
|
[NCBI]
|
1.20862e-07
|
|
|
CEACAM5
|
[NCBI]
|
2.8569e-10
|
|